Literature DB >> 16013590

Analysis of ethyl glucuronide in human serum by capillary electrophoresis with sample self-stacking and indirect detection.

L Krivánková1, J Caslavska, H Malásková, P Gebauer, W Thormann.   

Abstract

Ethyl glucuronide (EtG), a metabolite of ethanol, is a marker of recent alcohol consumption. In the past few years, its analysis in body fluids has attracted considerable attention because it closes a gap between short time and long time alcohol markers such as ethanol and carbohydrate-deficient transferrin, respectively. The capillary zone electrophoresis (CZE) analysis of EtG in model mixtures and human serum is reported using uncoated and coated fused-silica capillaries together with acidic buffers in the pH range between 3.2 and 4.4 and indirect detection. In these approaches, separation of EtG from endogenous macro- and microcomponents (anionic serum components of high and low concentration, respectively) is based upon transient isotachophoretic stacking referred to as sample self-stacking. The selection of a favorable bufferco-ion and pH is shown to be crucial for optimized sensitivity. Abuffercomposed of 10 mM nicotinic acid and epsilon-aminocaproic acid (pH 4.3) is demonstrated to provide a detection limit for EtG in serum of 0.1 microg/ml, a value that is relevant for clinical and forensic purposes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16013590     DOI: 10.1016/j.chroma.2004.11.099

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  A high-performance liquid chromatographic-tandem mass spectrometric method for the determination of ethyl glucuronide and ethyl sulfate in urine validated according to forensic guidelines.

Authors:  M E Albermann; F Musshoff; B Madea
Journal:  J Chromatogr Sci       Date:  2012-01       Impact factor: 1.618

2.  A novel and an effective analytical approach for the LC-MS determination of ethyl glucuronide and ethyl sulfate in urine.

Authors:  Donata Favretto; Alessandro Nalesso; Giampietro Frison; Guido Viel; Pietro Traldi; Santo Davide Ferrara
Journal:  Int J Legal Med       Date:  2009-10-27       Impact factor: 2.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.